Your browser is no longer supported. Please, upgrade your browser.
Settings
FLDM Fluidigm Corporation daily Stock Chart
FLDM [NASD]
Fluidigm Corporation
Index- P/E- EPS (ttm)-2.53 Insider Own0.20% Shs Outstand29.07M Perf Week9.49%
Market Cap204.65M Forward P/E- EPS next Y-2.00 Insider Trans485.92% Shs Float28.94M Perf Month57.85%
Income-71.20M PEG- EPS next Q-0.58 Inst Own98.70% Short Float9.28% Perf Quarter-20.90%
Sales110.10M P/S1.86 EPS this Y-0.90% Inst Trans-2.12% Short Ratio9.13 Perf Half Y-35.47%
Book/sh2.34 P/B3.01 EPS next Y22.80% ROA- Target Price8.55 Perf Year-30.37%
Cash/sh2.45 P/C2.87 EPS next 5Y-8.06% ROE- 52W Range4.31 - 11.24 Perf YTD-34.88%
Dividend- P/FCF- EPS past 5Y26.50% ROI-15.70% 52W High-37.37% Beta3.18
Dividend %- Quick Ratio3.10 Sales past 5Y27.90% Gross Margin57.00% 52W Low63.34% ATR0.43
Employees584 Current Ratio3.90 Sales Q/Q-22.40% Oper. Margin- RSI (14)62.22 Volatility7.00% 7.45%
OptionableYes Debt/Eq2.87 EPS Q/Q-111.20% Profit Margin- Rel Volume0.90 Prev Close7.11
ShortableYes LT Debt/Eq2.87 EarningsNov 03 BMO Payout- Avg Volume294.04K Price7.04
Recom2.30 SMA2014.66% SMA5016.56% SMA200-14.58% Volume263,109 Change-0.98%
Aug-05-16Reiterated Mizuho Buy $11 → $12
Aug-05-16Reiterated Cantor Fitzgerald Buy $13 → $11
May-05-16Reiterated Mizuho Buy $8 → $11
Apr-12-16Reiterated Leerink Partners Outperform $20 → $15
Jan-07-16Initiated Deutsche Bank Buy $18
Oct-30-15Upgrade Cantor Fitzgerald Hold → Buy $15 → $12
Oct-30-15Reiterated Mizuho Neutral $15 → $8
Aug-27-15Initiated Cantor Fitzgerald Hold
Aug-07-15Reiterated Mizuho Neutral $30 → $15
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
May-08-15Reiterated Maxim Group Buy $52 → $44
May-08-15Downgrade Mizuho Buy → Neutral $50 → $30
May-06-14Reiterated Maxim Group Buy $65 → $52
Apr-23-14Upgrade Mizuho Neutral → Buy $43 → $50
Mar-21-14Reiterated Maxim Group Buy $52 → $65
Feb-03-14Reiterated Oppenheimer Outperform $46 → $52
Jan-14-14Reiterated Mizuho Neutral $30 → $43
Dec-18-13Reiterated Maxim Group Buy $33 → $42
Oct-31-13Reiterated Mizuho Neutral $19 → $30
Oct-31-13Reiterated Maxim Group Buy $26 → $33
Dec-01-16 09:37AM  5 Stocks Under $10 Poised for Big Breakouts
Nov-29-16 01:00PM  Fluidigm to Present at Piper Jaffray 28th Annual Healthcare Conference GlobeNewswire
Nov-22-16 05:24PM  Medtronic, Patterson Among Day's Biggest Losers, Trump Continues to Pressure Healthcare Sector -7.34%
09:09AM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights of Secu
09:00AM  Fluidigm Corporation Adopts Tax Benefit Preservation Plan to Protect Its Net Operating Loss Carryforwards GlobeNewswire
Nov-17-16 01:04PM  FLUIDIGM CORP Financials
Nov-10-16 12:26PM  5 Stocks Insiders Love Right Now +9.14%
08:30AM  Fluidigm Introduces High-Parameter Maxpar Mass Cytometry Panels for Immuno-Oncology Research GlobeNewswire
Nov-09-16 08:00AM  Fluidigm and GenomOncology Partner to Provide Automated Oncology NGS Library Preparation With Molecular Interpretation and Reporting GlobeNewswire +7.41%
06:05AM  FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report
Nov-08-16 12:03PM  ETFs with exposure to Fluidigm Corp. : November 8, 2016 +11.88%
Nov-07-16 11:23AM  Fluidigm Corp. :FLDM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7, 2016
Nov-05-16 11:12AM  Edited Transcript of FLDM earnings conference call or presentation 3-Nov-16 9:00pm GMT
Nov-04-16 05:03AM  Fluidigm reports 3Q loss
Nov-03-16 04:27PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:07PM  Fluidigm Announces Third Quarter Financial Results GlobeNewswire
07:07AM  Preliminary Q3 2016 Fluidigm Corp Earnings Release - Before Market Open
Oct-31-16 11:10AM  What Makes Fluidigm (FLDM) a Strong Sell?
Oct-24-16 04:05PM  Fluidigm to Report Q3 2016 Financial Results and Host Conference Call GlobeNewswire
06:03AM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and E
Oct-19-16 05:00PM  Fluidigm Names S. Christopher Linthwaite as New Chief Executive Officer GlobeNewswire +7.08%
Oct-17-16 11:48AM  Daily Wrap: The Biggest Hedge Fund Moves of the Day at Insider Monkey
Oct-14-16 06:05AM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Oct-13-16 10:10AM  Fluidigm Stumbles on Preliminary Q3 Results -33.90%
02:17AM  Todays Trending Stocks: Fluidigm, CSX, Wells Fargo, and More at Insider Monkey
Oct-12-16 04:05PM  Fluidigm Announces Preliminary Third Quarter 2016 Revenue GlobeNewswire
Oct-10-16 09:41AM  ETFs with exposure to Fluidigm Corp. : October 10, 2016
Oct-07-16 06:09PM  Columbia Wanger Sold 2 Stakes in September
Oct-04-16 01:09PM  Fluidigm Corp (FLDM): Levin Capital Strategies Boosts Its Stake at Insider Monkey
Sep-28-16 09:46AM  ETFs with exposure to Fluidigm Corp. : September 28, 2016
Sep-14-16 10:07AM  ETFs with exposure to Fluidigm Corp. : September 14, 2016
Sep-13-16 04:08PM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers
Aug-30-16 11:11AM  ETFs with exposure to Fluidigm Corp. : August 30, 2016
Aug-15-16 10:23AM  ETFs with exposure to Fluidigm Corp. : August 15, 2016
Aug-11-16 12:12PM  Fluidigm Corp. :FLDM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
Aug-09-16 06:06AM  FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report
Aug-05-16 12:46PM  Edited Transcript of FLDM earnings conference call or presentation 4-Aug-16 9:00pm GMT -14.46%
Aug-04-16 06:11PM  Fluidigm reports 2Q loss
05:23PM  Fluidigm Receives ISO 13485 and ISO 9001 Certification at San Francisco and Singapore Facilities GlobeNewswire
04:18PM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
04:15PM  Fluidigm Recieves ISO 13485 and ISO 9001 Certification at San Francisco and Singapore Facilities GlobeNewswire
04:15PM  Fluidigm Introduces New High-Throughput Targeted NGS Library Preparation System GlobeNewswire
04:05PM  Fluidigm Appoints New President and Chief Operating Officer GlobeNewswire
04:01PM  Fluidigm Announces Second Quarter Financial Results GlobeNewswire
07:07AM  Q2 2016 Fluidigm Corp Earnings Release - Before Market Open
Jul-28-16 04:01PM  Fluidigm to Announce Q2 2016 Financial Results and Host Conference Call for Investors GlobeNewswire
Jun-09-16 09:00AM  Fluidigm Announces New Customer Inspiration Center in Canada for Mass Cytometry GlobeNewswire
May-23-16 04:56PM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
May-16-16 09:00AM  Fluidigm Introduces Single-Cell TCR Sequencing on the C1 System at Immunology 2016 GlobeNewswire
May-12-16 04:43PM  ETFs with exposure to Fluidigm Corp. : May 12, 2016
May-11-16 11:41AM  Fluidigm Corp. :FLDM-US: Earnings Analysis: Q1, 2016 By the Numbers
May-09-16 06:11PM  FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report
May-05-16 03:42PM  Edited Transcript of FLDM earnings conference call or presentation 5-May-16 12:30pm GMT +7.11%
09:53AM  Fluidigm reports 1Q loss
07:39AM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:25AM  Fluidigm Announces First Quarter Financial Results GlobeNewswire
07:07AM  Q1 2016 Fluidigm Corp Earnings Release - Before Market Open CCBN
Apr-22-16 04:24PM  Fluidigm to Announce Q1 2016 Financial Results and Host Conference Call for Investors GlobeNewswire
Apr-12-16 08:44AM  Fluidigm Announces New Integrated Fluidic Circuits for Single-Cell Genomics on the C1 System GlobeNewswire
Apr-07-16 01:27PM  Starboard Cuts Stake in Quantum Corp (QTM), Tiger Global Jettisons Majority of Pure Storage Inc. (PSTG) Holding, Plus 2 Other Moves at Insider Monkey
Apr-06-16 01:00PM  Clontech Laboratories, Inc. Releases the SMART-Seq v4 Ultra Low Input RNA Kit for the Fluidigm C1 System PR Newswire
Mar-01-16 05:00PM  Fluidigm to Present at Cowen and Company 36th Annual Health Care Conference GlobeNewswire
Feb-29-16 06:35AM  FLUIDIGM CORP Files SEC form 10-K, Annual Report
Feb-10-16 12:20PM  Fluidigm Q4 Loss Narrower than Expected, Revenues Fall Y/Y
Feb-08-16 10:14AM  Fluidigm Corp. Earnings Analysis: 2015 By the Numbers -15.59%
Feb-05-16 06:02PM  Edited Transcript of FLDM earnings conference call or presentation 4-Feb-16 10:00pm GMT
Feb-04-16 04:55PM  Fluidigm reports 4Q loss
04:08PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:00PM  Fluidigm Announces Fourth Quarter and Full Year 2015 Financial Results GlobeNewswire
07:07AM  Q4 2015 Fluidigm Corp Earnings Release - After Market Close
Jan-28-16 06:30PM  FLUIDIGM TO ANNOUNCE Q4-FULL YEAR 2015 FINANCIAL RESULTS at noodls
05:30PM  Fluidigm to Announce Q4-Full Year 2015 Financial Results and Host Conference Call for Investors GlobeNewswire
Jan-19-16 01:40PM  Fluidigm's Q4 Preliminary Results Fail to Woo Investors -14.29%
Jan-15-16 01:10PM  Accuray Expands EIMEA Footprint with New Installations
Jan-12-16 08:17AM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:00AM  Fluidigm Announces Preliminary Full Year and Fourth Quarter 2015 Revenue GlobeNewswire
Jan-07-16 12:37PM  Coverage initiated on Fluidigm by Deutsche Bank
Dec-24-15 03:06PM  Fluidigm Mutes the Performance of IHIs Small Caps
Dec-23-15 02:10PM  At the Top of IHI, NxStage Extends Its Rally
08:00AM  Pre-market Insights on Healthcare Sector -- Fluidigm, AngioDynamics, Tandem Diabetes Care, and BioTelemetry Accesswire
Dec-16-15 04:59PM  The iShares US Medical Devices ETF (IHI) Has Put Nothing under the Tree in DecemberYet
Dec-14-15 04:07PM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
07:55AM  Today's Market Driven by Key Factors - Free Research on Koppers Holdings, Dimension Therapeutics, Fluidigm and Orasure Technologies Accesswire
Dec-11-15 01:20PM  Fluidigm Now a Strong Buy on Portfolio & Pipeline Strength -6.21%
Dec-02-15 09:20AM  Three Reasons Investors Should Consider Pressure BioSciences Accesswire -6.35%
08:56AM  Fluidigm (FLDM): Strong Industry, Solid Earnings Estimate Revisions
Dec-01-15 01:20PM  Allscripts Healthcare Announces New Share Buyback Worth $150M
Nov-30-15 02:05PM  Natus Medical (BABY) Hits 52-Week High on Solid Q3 Results +7.26%
01:20PM  Cardinal Health: Strong Buy on Strong Q1, Positive Outlook
08:54AM  Surging Earnings Estimates Signal Good News for Fluidigm (FLDM)
04:01AM  Do Hedge Funds Love Tokai Pharmaceuticals Inc (TKAI)? at Insider Monkey
Nov-27-15 01:40PM  Fluidigm's Juno on Time's 2015 Invention List, Shares Up
Nov-24-15 01:00PM  TIME Magazine Selects Fluidigms Juno system as One of the Best Inventions of 2015 Business Wire
09:00AM  Fluidigm to Present at Piper Jaffray 27th Annual Healthcare Conference Business Wire
Nov-21-15 02:29PM  Hedge Funds Are Yanking Their Capital Out Of Fluidigm Corporation (FLDM) at Insider Monkey
Nov-12-15 03:39PM  IHI Moves into the Red as Market Witnesses Weakness
02:16PM  6 Stocks to Watch -- 3 to Short and 3 to Buy at TheStreet
Nov-09-15 03:50PM  FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report
Nov-02-15 05:01PM  IHIs Bottom Ten Stocks Outperform Other Biotechnology ETFs +7.03%
04:59PM  IBB Was among the Best Biotechnology ETFs for the Week
Fluidigm Corporation creates, manufactures, and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics. It offers C1 single-cell auto prep system that isolates and processes individual cells for genomic analysis; access array system, which enables automated polymerase chain reaction (PCR)-based target enrichment, barcoding, and tagging of targeted sequencing libraries and facilitates parallel amplification; Juno system and integrated fluidic circuits (IFCs), which automate the preparation of samples for genomic analysis; and Callisto system and IFC that enable automated cell culture and combinatorial dosing on a single device. The company also provides Polaris system and IFCs; Biomark HD system, a PCR analytical instrument for gene expression analysis, single-cell targeted gene expression analysis, microRNA analysis, single nucleotide polymorphism (SNP) genotyping, and digital PCR; and Helios/CyTOF 2 system, a mass cytometry instrument that performs single-cell protein analysis. In addition, it offers C1, access array, dynamic array, digital array, flex six, and high-throughput C1 mRNA sequencing IFCs; and Delta Gene and SNP type assays, access array target-specific primers, and targeted sequencing prep primers, as well as Maxpar reagents. Further, the company provides imaging mass cytometer instrument and reagents, laser ablation module, and other Maxpar reagent products. It serves academic institutions; clinical laboratories; and pharmaceutical, biotechnology, and agricultural biotechnology companies through its direct sales force and support organizations, distributors, or sales agents. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Linthwaite Stephen ChristopherPresident & CEONov 30Buy6.3655,000350,06458,000Dec 02 04:19 PM
COLELLA SAMUEL DDirectorNov 30Buy6.3220,000126,47039,123Dec 02 04:18 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 07Buy4.386,00026,3096,343,743Nov 07 06:25 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 04Buy4.4211,78452,1046,337,743Nov 07 06:25 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 03Buy4.44141,416628,1586,325,959Nov 07 06:25 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 02Buy4.4717,40077,6966,184,543Nov 03 03:35 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 01Buy4.4330,902136,8356,167,143Nov 03 03:35 PM